Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal polysaccharide antigens are essential carbohydrate polymers, such as (1,3)-beta-D-glucan, galactomannan, and mannan, that form the structural backbone of the fungal cell wall (Erwig & Gow, 2016, Nature Reviews Microbiology). These molecules are unique to fungi and are absent in human cells, making them highly specific targets for both diagnostic assays and therapeutic interventions. In the host, these antigens act as pathogen-associated molecular patterns (PAMPs) that trigger innate immune responses through receptors like Dectin-1 (Brown, 2006, Nature). Clinically, the detection of these antigens in serum or bronchoalveolar lavage fluid serves as a critical biomarker for the early diagnosis of life-threatening invasive fungal infections (Karageorgopoulos et al., 2011, Clinical Infectious Diseases). Therapeutic agents like echinocandins (e.g., caspofungin) work by inhibiting the synthesis of these polysaccharides, specifically targeting the (1,3)-beta-D-glucan synthase enzyme to cause cell wall instability and fungal death (StatPearls, 2023). Additionally, these antigens are the focus of research into monoclonal antibodies and vaccines aimed at enhancing the host's ability to clear fungal pathogens.
Inhibition of (1,3)-beta-D-glucan synthase, leading to depletion of cell wall polysaccharides and osmotic instability; direct binding by monoclonal antibodies for opsonization and clearance.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal polysaccharide antigens.